Treatment of Human Disseminated Strongyloidiasis with a Parenteral Veterinary Formulation of Ivermectin
Open Access
- 1 July 2005
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (1) , e5-e8
- https://doi.org/10.1086/430827
Abstract
There are no parenteral antihelminthic drugs licensed for use in humans. We report the successful treatment of disseminated strongyloidiasis with a pKeywords
This publication has 16 references indexed in Scilit:
- Strongyloides stercoralisin the Immunocompromised PopulationClinical Microbiology Reviews, 2004
- Clinical presentation and diagnostic sensitivity of laboratory tests for Strongyloides stercoralis in travellers compared with immigrants in a non‐endemic countryTropical Medicine & International Health, 2003
- Parenteral ivermectin in Strongyloides hyperinfectionThe Lancet, 2000
- A Comparative Trial of a Single-Dose Ivermectin Versus Three Days of Albendazole for Treatment of Strongyloides Stercoralis and Other Soil-Transmitted Helminth Infections in ChildrenThe American Journal of Tropical Medicine and Hygiene, 1996
- Efficacy of Ivermectin in the Treatment of Strongyloidiasis Complicating AIDSClinical Infectious Diseases, 1993
- Ivermectin binds avidly to plasma proteinsEuropean Journal of Clinical Pharmacology, 1990
- Global Prevalence of Strongyloidiasis: Critical Review with Epidemiologic Insights into the Prevention of Disseminated DiseaseClinical Infectious Diseases, 1989
- The relative systemic availability of ivermectin after administration as capsule, tablet, and oral solutionEuropean Journal of Clinical Pharmacology, 1988
- Syndrome of Hyperinfection with Strongyloides stercoralisClinical Infectious Diseases, 1981
- Fatal Strongyloidiasis in Patients Receiving CorticosteroidsNew England Journal of Medicine, 1966